Ganga Pharmaceuticals Ltd.
BSE: 539680
₹12.50
₹0.50
(4.17%)
As on 08-Sep-2026IST
Market cap
₹7 Cr
Revenue (TTM)
₹3 Cr
P/E Ratio
73.2
P/B Ratio
0.9
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹0 Cr
-
ROE
1.2 %
-
ROCE
3.2 %
-
Industry P/E
30.84
-
EV/EBITDA
26.8
-
Debt to Equity
0.2
-
Book Value
₹13.5
-
EPS
₹0.2
-
Face value
10
-
Shares outstanding
5,911,500
10 Years Aggregate
CFO
₹-3.23 Cr
EBITDA
₹1.76 Cr
Net Profit
₹0.82 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Ganga Pharma
| -- | -- | -- | -14.4 | -2.4 | -- | -- |
|
BSE Healthcare*
| 19.1 | 2.3 | 8.1 | 14.3 | 22.5 | 14.5 | 12.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Ganga Pharma
|
12.5 | 7.4 | 2.6 | 0.1 | -- | 1.2 | 73.2 | 0.9 |
| 26.9 | 15.3 | 6.6 | 0.6 | 14.1 | 4.2 | 27.8 | 1.4 | |
| 515.4 | 6,425.7 | 851.5 | 236.3 | 36.3 | 57.6 | 27.2 | 12.1 | |
| 170.4 | 222.2 | 135.7 | -26.4 | -17.0 | -320 | -- | -11.0 | |
| 22.7 | 37.4 | 49.3 | 0.6 | 1.4 | 3.6 | 61.3 | 2.2 | |
| 37.7 | 36.8 | 69.6 | 1.8 | 3.4 | 4.1 | 20.8 | 1.0 | |
| 160.2 | 244.7 | 200.7 | 17.1 | -- | 28.7 | 14.3 | 3.6 | |
| 115.0 | 72.1 | 79.7 | 3.5 | 7.0 | 14.2 | 20.6 | 2.7 | |
| 167.9 | 168.2 | 89.9 | 7.2 | -- | 13.7 | 18.7 | 2.7 | |
| 24.2 | 21.7 | 71.8 | 2.8 | -- | 18.2 | 8.8 | 1.1 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Ganga Pharma
Manufacture of allopathic pharmaceutical preparations
-
Incorporated
1989
-
Chairman
Sanjay Vyankatesh Kulkarni
-
Managing Director
Bharat Brijmohan Sharma
-
Headquarters
Palghar, Maharashtra
-
Website
Looking for more details about Ganga Pharmaceuticals Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Ganga Pharma
What is the current share price of Ganga Pharmaceuticals Ltd Today?
The share price of Ganga Pharmaceuticals Ltd is ₹12.50 (BSE) as of 08-Sep-2026 IST. Ganga Pharmaceuticals Ltd has given a return of -2.41% in the last 3 years.
What is the current PB & PE ratio of Ganga Pharmaceuticals Ltd?
The P/E ratio of Ganga Pharmaceuticals Ltd is 73.16 times as on 08-Sep-2026, a 137 premium to its peers’ median range of 30.84 times.
The P/B ratio of Ganga Pharmaceuticals Ltd is 0.92 times as on 08-Sep-2026, a 86 discount to its peers’ median range of 6.38 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
62.24 |
0.76 |
2024 |
0.00 |
0.00 |
2023 |
0.00 |
0.00 |
2022 |
109.87 |
0.77 |
2021 |
0.00 |
0.00 |
What is the 52 Week High and Low of Ganga Pharmaceuticals Ltd?
The 52-week high and low of Ganga Pharmaceuticals Ltd are Rs 13.97 and Rs 9.35 as of 22-Sep-2026.
What is the market cap of Ganga Pharmaceuticals Ltd?
Ganga Pharmaceuticals Ltd has a market capitalisation of ₹ 7 Cr as on 08-Sep-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Ganga Pharmaceuticals Ltd?
Before investing in Ganga Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.